Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Teva
Cantor Fitzgerald
Medtronic
Chubb
McKesson
Citi
Moodys
AstraZeneca

Generated: December 10, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 02010136

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Hoffmann La RocheBONIVAibandronate sodiumTABLET;ORAL021455-002Mar 24, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeTREATMENT AND PREVENTION OF OSTEOPOROSIS
Hoffmann La RocheBONIVAibandronate sodiumTABLET;ORAL021455-002Mar 24, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeTREATMENT AND PREVENTION OF OSTEOPOROSIS
ApilACTONELrisedronate sodiumTABLET;ORAL020835-005Apr 22, 2008ABRXYesYes► Subscribe► Subscribe► SubscribeY
Hoffmann La RocheBONIVAibandronate sodiumTABLET;ORAL021455-002Mar 24, 2005ABRXYesYes► Subscribe► Subscribe► SubscribeTREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF IBANDRONIC ACID
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist